×

Blame game escalates in EpiPen price-gouging charge

6:25 AM ET Fri, 26 Aug 2016

CNBC's Meg Tirrell reports there is lots of finger-pointing in the pharmaceutical space after Mylan's CEO accuses the system of incentivizing higher drug prices.